Does testosterone therapy really affect your blood in hidden ways?

What did @k8.den actually say?

The creator, who claims a background in human physiology and pre-med coursework, made two core claims: testosterone increases red blood cell count (which they say explains an increase in iron), and testosterone "affects the strength and ability of your blood vessels." They then shared a personal anecdote about chronic nosebleeds resolving after starting testosterone about five and a half years ago, attributing it to vascular repair driven by testosterone exposure.

This is a stitched response to another creator who apparently discussed unexpected effects of testosterone. The framing is educational but casual, and the personal story is woven into what is presented as physiological explanation. It's worth separating the science from the autobiography here, because one is checkable and one is not.

Does the science back this up?

The red blood cell claim is accurate and well-documented. The vascular claim is more complicated, and the nosebleed story is plausible but not a clean illustration of the mechanism described.

On erythrocytosis: testosterone stimulates erythropoiesis primarily by increasing erythropoietin (EPO) production in the kidneys and suppressing hepcidin, a hormone that regulates iron availability. The result is a measurable rise in hemoglobin, hematocrit, and red blood cell mass. This is one of the most consistently observed effects of testosterone therapy. Bhasin et al. (2010, New England Journal of Medicine) documented dose-dependent increases in hemoglobin in testosterone-treated men. Studies in transgender men on testosterone, such as Gava et al. (2016, Journal of Sexual Medicine), show similar rises within the first six months of therapy.

On vascular effects: testosterone does influence vascular biology, but "strength and ability" is an oversimplification. Research shows testosterone affects vascular smooth muscle tone, nitric oxide signaling, and endothelial function. Ong et al. (2011, International Journal of Andrology) reviewed evidence that testosterone has vasodilatory effects. But whether this translates to "repairing" a weak nasal blood vessel is a significant leap.

What did they get wrong (or right)?

The red blood cell explanation is largely right, though the framing around iron is slightly off. The increase in red blood cells does affect iron metabolism, but the direction of effect is nuanced. Testosterone suppresses hepcidin, which increases iron absorption and incorporation into red blood cells. Some people on testosterone actually see serum iron shift around as their bodies ramp up red blood cell production. Saying testosterone causes an "increase in iron" without qualification could mislead someone into thinking their iron stores go up uniformly, when the picture is more complicated.

The vascular repair claim is where the video gets shaky. The creator says "a bunch of the influence of testosterone... that weak blood vessel on my nose was finally able to repair itself." This implies a direct causal mechanism between testosterone-driven vascular changes and epistaxis resolution. That is not established science. Nosebleed frequency is affected by many factors including humidity, mucosal hydration, blood pressure, and clotting. Estrogen also has known effects on mucosal tissue, so the reduction in estrogen during testosterone therapy in a transgender man could plausibly affect nasal mucosa, but that is a different mechanism than the one described.

Credit where it is due: the core public health message, get blood work regularly when starting or adjusting testosterone, is genuinely good advice and not said often enough in these spaces.

What should you actually know?

If you are on testosterone therapy, erythrocytosis is one of the most clinically significant lab findings to monitor. Hematocrit above 54 percent increases blood viscosity and raises the risk of thrombotic events, including stroke and pulmonary embolism. The Endocrine Society's 2018 clinical practice guidelines recommend checking hematocrit at baseline, three to six months after starting therapy, and annually once stable.

The iron metabolism piece deserves more attention than it gets. Some people starting testosterone develop relative iron deficiency as their bodies ramp up red blood cell production faster than dietary iron can keep up. If you are feeling fatigued on testosterone and assume it is just adjustment, it is worth asking your provider to check a full iron panel alongside your CBC.

On the vascular side: testosterone does influence endothelial function and vascular tone, but the evidence on net cardiovascular benefit versus risk is still being sorted out in long-term studies. Do not take a resolved nosebleed as a signal your cardiovascular system is thriving. Get the labs.

Should you take medical cues from this video?

The call to action, get regular blood work, is correct and worth amplifying. The physiological explanation is mostly sound with some gaps. The personal anecdote is interesting but should not be read as a mechanistic explanation for what testosterone does to blood vessels. Anecdotes do not establish causation, and this creator, to their credit, is not really claiming they do. The problem is that the story is positioned immediately after a causal claim, which blurs the line.

If you are starting testosterone or adjusting your dose, work with a licensed provider who can order and interpret CBC with differential, hematocrit, iron studies, and a lipid panel. This video points you in the right direction. It does not give you the full map.